Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
7,371 total articles
Intuitive Machines (LUNR) is trading near $28.41 after a run from a $6.75 52-week low as investor focus shifts from a single lunar mission to recurring cislunar services. The company shows early revenue upside via government and commercial lunar contracts (including a $180.4 million award), strong liquidity per share, but valuation metrics (P/S ~20…
Abbott Laboratories (ABT) is trading near its 52-week low at $93.71 while still generating strong free cash flow and paying a $0.63 quarterly dividend (2.5% yield). A combination of an earnings-guidance reset, acquisition-related dilution fears, and macro volatility pushed the stock lower. Fundamentals—$11.16B in Q1 revenue, solid device and diabet…
Netflix's latest U.S. price increases and continued ad monetization give the company clear levers to protect margins and FCF. The stock pulled back after guidance conservatism; that creates a tactical buying window for disciplined traders who want exposure to durable streaming economics. Trade plan: enter $92.00, stop $80.00, target $110.00, mid te…
Bright Horizons (BFAM) looks positioned for a re-rating. At roughly $85, the stock trades at ~24x earnings with $258M in trailing free cash flow and an enterprise value near $5.5B. Improving technicals, manageable leverage and reopening tailwinds create a clear risk-reward for a mid-term trade targeting $110 over the next 45 trading days, with a $7…
Tesla looks richly valued on traditional metrics, trading near its 50-day average with modest technical setup and heavy short activity. Given elevated expectations and the company's huge market cap, a muted post-earnings price reaction is a plausible outcome. This idea outlines a short-term short-into-strength trade: enter on a rally, keep a tight …
Occidental Petroleum (OXY) has pulled back from recent highs after a brief oil reprieve. The company still generates meaningful free cash flow, trades at a reasonable enterprise multiple, and just posted a high-impact Gulf discovery that can re-price the story if oil stays resilient. This trade idea sets an exact entry, stop and target for a mid-te…
Pinterest has traded down from its 52-week highs as ad-revenue worries, tariff chatter and multiple securities filings dominated headlines. The stock now offers a mid-term contrarian entry around $20.50 with defined risk, supported by positive free cash flow, reasonable valuation metrics and improving technical momentum. This is not a no-risk trade…
Spotify has shifted from pure music streaming to a data-rich platform that can monetize podcasts, video, and personalized ad formats. Recent earnings and product moves suggest durable margin expansion and an accelerating monetization runway. This trade uses a measured long entry with a clear stop and a 180-trading-day target to capture the next leg…
Apple slid after Tim Cook's announced transition to executive chairman and John Ternus's promotion to CEO. The move is meaningful politically and operationally, but Apple’s scale, cash generation and product moat remain intact. This trade idea outlines a mid-term swing entry at $267.00 with a $295.00 target and a $255.00 stop — a risk/reward setup …
We expect the US dollar to face cyclical pressure over the coming weeks to months. Tactical longs in EUR/USD and AUD/USD and a short on the DXY offer asymmetric risk-reward if US yields soften and external growth momentum reasserts. The plan below includes exact entries, stops and targets with horizon guidance and clear risk points.
Compass Pathways (CMPS) is a beaten-down biotech turned momentum leader after regulatory acceleration and positive Phase 3 data for COMP360. The stock is richly priced for a biotech but fundamentals and market structure (heavy short interest and large short volume on 04/20/2026) create a tactical long opportunity. This trade idea lays out entry, st…
Equity Bancshares (EQBK) looks like a pragmatic buy here: the stock sits below $1 billion market cap, generates meaningful free cash flow, and has a recent history of earnings beats and targeted M&A. Valuation metrics are not demanding on a price-to-book basis, short interest is elevated, and technicals are neutral-to-bullish. This trade lays out a…
BridgeBio (BBIO) is staging a transition from a pure rare-disease developer to a commercial-stage company with optionality for oncology expansion. Recent wins (Attruby long-term mortality data, positive BBP-418 Phase 3 readout, achondroplasia data) should drive revenue and M&A firepower that could be redeployed into KRAS-targeted assets or partners…
Valero’s refining cash flow has surged amid diesel and gasoline spikes, producing free cash flow of roughly $3.7B and a balance sheet that supports outsized capital returns. With the stock trading near $229, we outline a mid-term long trade designed to capture roughly 14% upside to $261 while protecting capital with a $215 stop.
United Natural Foods (UNFI) looks set to keep climbing from here: improving adjusted EPS, positive free cash flow, and a valuation that implies limited expectations create room for upside. Expect gains to be measured rather than explosive — buy size accordingly and use a tight stop.
Jacobs Solutions (J) posts healthy margins, solid cash flow and a rising dividend, yet recent price action shows muted investor appetite and elevated short activity. That divergence creates a tactical mid-term long trade: enter near current levels, keep a disciplined stop, and target a move back toward the $140s as the market re-prices durable cash…
Suncor's integrated footprint, heavy-crude exposure and solid dividend make it my top Canada energy pick on a post-conflict crude price regime. I'm raising my buy-on-weakness limit to $55/share, with a $72 target and a $50 hard stop, sized for a mid-term rebound tied to sustained oil strength and improving refining margins.
Taiwan Semiconductor Manufacturing (TSM) is trading nearer to the cyclical trough than to the structural growth story the company now represents. Strong Q1 prints, a 72% foundry share, and analyst forecasts of high-teens to 40%+ earnings growth support a long-biased trade on a near-term pullback. Entry $362.00, stop $338.00, target $420.00 for a lo…
Accenture's combination of scale, cash generation and targeted AI M&A/partnerships creates a low-hanging path to margin expansion and share gains in consulting, cloud migration and cybersecurity. We initiate a tactical long with precise entry, stop and two upside targets tied to catalysts over the next 46-180 trading days.
Candel Therapeutics (CADL) looks like a constructive buy right now. Positive clinical readouts, a funded commercialization push and bullish technical momentum have pushed the stock toward a new 52-week high. With market cap near $545M, meaningful cash on the balance sheet and a clear product roadmap, a disciplined long position offers asymmetric up…
An anticipated SpaceX IPO at a $1.75 trillion valuation and a jaw-dropping 220x EV/EBITDA multiple could catalyze a broad re-rating across aerospace & defense. That repricing would lift multiples for primes, launch suppliers, and satellite-capable contractors. Tactical trade: go long the iShares U.S. Aerospace & Defense ETF (ITA) to capture a secto…
Qfin trades at bargain-bin multiples and an eye-catching 10%+ yield, yet a tightening regulatory environment for consumer lending in China has turned tomorrow’s earnings and dividend into catalysts and potential landmines. This trade idea targets a mid-term rebound while respecting regulatory uncertainty and the upcoming ex-dividend date.
Agnico Eagle's string of strategic buys — including consolidation in Finland and the Fingold purchase — materially expands low-risk, high-return optionality. At a $105.7B market cap and a P/E of 24.3, the stock already reflects quality; I argue the market is under-pricing the production and synergy upside from the new district consolidation. Action…
Patria has strengthened scale and diversified revenue with three sizeable acquisitions that materially lift Fee-Earning AUM and Fee Related Earnings. The stock is a buy from a fundamentals perspective, but after a busy M&A stretch I favor a tactical, size-conscious long with a clear stop and a mid- to multi-month target.
SKYX Platforms (SKYX) has stacked strategic partnerships, retail launches, and institutional capital in recent quarters. That combination creates a clear mid-term re-rating pathway if deployments and AI-enabled features gain commercial traction. At the same time the company is unprofitable, burning cash, and sitting in a crowded short-interest prof…
